Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis

Trial Profile

Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Sponsors Bayer
  • Most Recent Events

    • 07 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 22 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Jul 2016.
    • 21 Jun 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top